Table 4.
Recommendations on therapeutic drug monitoring during antifungal prophylaxis
Intention | Intervention | SoR | QoE | |
---|---|---|---|---|
Drug | Target level | |||
Achieve exposure effective for antifungal prophylaxis and reduce toxicity | Voriconazole | 1–2 mg/L | B | IItu |
Posaconazole | > 500 ng/ml | C | IItu |